Consistent with these histological findings,Fgf13 KO attenuated α-SMA accumulation after 12 weeks of TAC, indicating that FGF13 is involved in activation inhibition in cardiac fibroblasts compared with that in the TAC hearts (Figure 2F,G). This evidence concerns the gene ACTA1 and persistent truncus arteriosus.